Müller, Sabrina
Maywald, Ulf
Timmermann, Hartmut
Unmüßig, Victoria
Welte, Robert
Hardtstock, Fränce
Wilke, Thomas
Funding for this research was provided by:
GlaxoSmithKline (HO-14-14930)
Article History
Accepted: 7 February 2021
First Online: 24 February 2021
Declarations
:
: This study (HO-14-14930) is funded by GlaxoSmithKline.
: Fraence Hardtstock and Sabrina Mueller are employees of Ingress-Health. Ingress-Health work was financially supported by GSK. Thomas Wilke is an employee of IPAM and received funding from GSK to conduct this study. Thomas Wilke has received honoraria from several pharmaceutical/consultancy companies (Novo Nordisk, Abbvie, Merck, GSK, BMS, LEO Pharma, Astra Zeneca, Bayer, Boehringer Ingelheim, Pharmerit). Victoria Unmuessig and Robert Welte are GSK employees and hold stocks and shares. Ulf Maywald has no potential conflicts of interest, except those potentially related to his employer, AOK PLUS. Hartmut Timmermann has received consultancy fees and grants from several pharmaceutical companies.
: The study was approved by the Ethics Committee of the University Medicine Rostock (Germany) and the Saxon State Ministry for Social Affairs and Consumer Protection.
: Not applicable.
: Not applicable.
: The data that support the findings of this study are abstracted from individual patient records. Data were available for research purposes from the sickness fund upon request, in an anonymized form. Because of the German data protection law (SGB X) and restrictions around revealing patients’ confidential information, data are neither publicly available nor can be shared further.
: Not applicable.
: All authors have completed the author consent form and made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content, and (3) final approval of the version to be submitted. Specifically, the main tasks the authors were engaged in were: FH, SM: study concept, statistical analysis, interpretation of results, writing all parts of the paper, review and revision; TW: study concept, project lead, participated in writing all parts of the paper; HT, VU, RW: study concept, interpretation of results, critical review of the manuscript; UM: data collection/validation, interpretation of results, critical review of the manuscript.